Home
NewsNewsINVO Fertility would be introducing time-lapse incubation technology at its Wisconsin clinic, hence offering high-quality lab care, creative patient solutions, and advanced embryo monitoring for improved fertility results.
INVO Fertility, Inc., a healthcare services fertility company that helps people get advanced reproductive treatment by setting up, acquiring as well as running fertility clinics along with related businesses and technologies, on March 5, 2026, went ahead and announced that its Wisconsin clinic would start using time-lapse incubation technology. This integration shows that INVO is indeed dedicated to providing modern, high-quality lab care and creative patient solutions, as well as to improving the quality of labs and clinics across its growing network.
According to COO of INVO, April McGhee, “INVO Fertility is proud to introduce this time-lapse incubation technology as part of our ongoing focus on quality and innovation and the expansion of additional patient service offerings. This technology enhances the tools available to our embryology teams while aligning with our commitment to delivering thoughtful, patient-centred fertility care.”
INVO is looking out to improve its clinics and help its clinical and laboratory teams and also throttle its mission of providing accessible, patient-centred fertility care by using proven new ideas like time-lapse incubation. This adoption shows that the company is keeping its promise to invest in cutting-edge technologies that improve the treatment journey for patients. It is also part of the company's larger plan to responsibly integrate cutting-edge reproductive technologies that provide real value to patients and doctors.
Remarks CEO Steve Shum, “Our approach to innovation is intentional. We focus on technologies that may enhance quality and outcomes while staying true to our mission of expanding access to fertility care through continuous, responsible innovation.”
The Stork Foundation for Infertility received a record 1,076 grant applications in 2026, with data revealing that 85% of applicants have no fertility treatment coverage for the care they are pursuing. Average anticipated next treatment costs stand at 19,149 USD, with 39% having already spent more than 10,000 USD out of pocket.
Future Health, A Global Initiative by Abu Dhabi has launched the Future Health Digital Health Innovation Challenge 2026, inviting global innovators to develop AI, software, and connected technology solutions across fertility, population health, and well-being. Three finalists will share USD 105,000 at GITEX 2026, with selected solutions eligible for incubation and scale.
La Trobe University and GonGlobal have entered a strategic collaboration to develop and validate AI and digital twin technologies for ART and IVF. The partnership will build AI-driven fertility care tools, including cohort matching digital twins and deep-learning models, to predict pregnancy outcomes and support personalised clinical decision-making.
IVI Institute has announced the acquisition of The World Egg and Sperm Bank (TWESB), founded in 2004 and operating from Scottsdale, Arizona. The move expands access to reproductive solutions for patients and clinics across the United States and Australia, combining TWESB’s network of 500+ screened donors with IVI Institute’s global clinical and scientific infrastructure.
Doctors at NHS Lothian in Edinburgh have performed the UK’s first testicular tissue transplant, reimplanting tissue frozen before chemotherapy in a 19-year-old patient with a serious blood disorder. The testicular tissue transplant, only the second reported worldwide, could eventually give thousands of young boys a realistic path to future fatherhood.
Flora Fertility and Clue have announced the Flora Clue fertility partnership, connecting the first individually owned fertility insurance platform with the world’s leading women-led cycle tracking app. FLORA policyholders receive complimentary Clue Plus access, while Clue’s community of over 100 million members gains early exposure to proactive fertility financial planning.
The World Health Organization releases its first comprehensive, evidence-based global guideline for infertility prevention, diagnosis, and treatment. Addressing one in six people of reproductive age worldwide, the guideline emphasizes equity, human rights, and standardized interventions to improve access to fertility care globally.
